BTS Biotechnologies

Difference between bacteria, virus and fungus in biotech

Difference between bacteria, virus and fungus in biotech

In the field of biotechnology, understanding the difference between bacteria, viruses, and fungi isn’t just a matter of vocabulary. It’s an essential step in mastering their roles, applications, and impacts on health, the environment, and industry. In 2025, with the rapid evolution of research tools and technologies, this knowledge becomes even more crucial. Whether for developing drugs, optimizing food production, or preserving the ecosystem, differentiating these microorganisms is the key to success. But how can you navigate this microscopic diversity? What precisely are their fundamental differences, their lifestyles, their interactions with humans, and their place in biotechnology? This is what I’m going to help you unravel, in order to provide a clear and precise vision of what these terms cover, often confused by the general public but radically different in laboratories. It’s a journey to the heart of the invisible, where each microbe has its own characteristics, challenges, and uses, from biofilms to vaccines and industrial fermentation.

Discover the innovations and applications of biotechnology, a rapidly expanding field that uses living organisms to improve health, agriculture, and the environment. Explore the latest trends, research, and technological advances that are transforming our future.

Bacteria: Living Organisms with Multifaceted Roles in Biotech

Bacteria are a bit like nature’s little artisans: they are single-celled living beings that play a key role in our planet, our bodies, and industry. But what specifically distinguishes a bacterium?

  • They are prokaryotic organisms , meaning they lack a defined nucleus, their genetic material being dispersed throughout their cytoplasm.There are millions of species, each adapted to a specific environment, whether in water, soil, or our own bodies.
  • Bacteria are capable of multiplying rapidly, sometimes in a matter of hours, which gives them an exceptional adaptability in biotechnology. For example, the production of certain drugs, such as insulin or growth hormone, uses modified bacteria. Roche, for example, uses advanced techniques to insert human genes into bacteria, allowing them to produce them in large quantities. Biotechnology is at the heart of the pharmaceutical industry, with players like Genzyme and Ipsen innovating in this field.But bacteria also represent a whole world of pathogens. Some cause diseases such as tuberculosis or salmonellosis, so how can we combat them? The answer lies in a detailed understanding of their metabolism and structure, allowing for the development of antibiotics or rapid detection techniques—for example, UV-visible spectroscopy or electrophoresis methods.
  • In research and development, companies like Thermo Fisher Scientific offer sophisticated equipment for analyzing these microorganisms. The key is to quickly identify their nature to effectively target their elimination or use. And if we want to go further, modeling biofilms or studying microbiotas, particularly those of the intestine, are enabling major advances in personalized medicine and nutrition. CharacteristicsDescription

Cell type

Prokaryotic, unicellular without nucleus

Reproduction

Rapid binary division (Hrs to Days) Biotech applications
Drug synthesis, bioremediation Danger
Pathogenic or beneficial depending on the species Viruses: parasites incapable of living alone
Viruses are another story. Both fascinating and formidable, they challenge our vision of life. Because, in reality, they are not really living beings in the traditional sense. Are they microorganisms like bacteria or fungi? Not really. Viruses do not have their own metabolism. They cannot produce energy or reproduce on their own. Their function is based on a single thing: infecting a host cell.
They are composed of a protective shell, called a capsid, which contains either DNA or RNA. Once inside a cell, they take control of the cellular machinery to produce copies of the virus.

In biotech, this ability is exploited for the production of vaccines or gene therapies. For example, some COVID-19 vaccines use modified viral vectors, such as those produced by Sanofi or GSK, to teach the immune system how to recognize the virus.

But the challenge with viruses is their ability to evolve rapidly. New variants are continually emerging, such as those of SARS in 2020 or the influenza virus, which complicates their control. Their spread, through coughing, contact, or even through the air, also makes them highly contagious infectious agents, requiring the development of effective prevention strategies.

  • Specific vaccines for each virus Antivirals to slow their life cycleStrict health measures
  • Research is also focusing on nanotechnology and synthetic biology to create safer viral vectors or to stop their ability to mutate. Some companies like GSK are innovating by offering messenger RNA vaccines, allowing rapid adaptation to new emerging viruses. AppearanceDetails
  • Composition Capsid + genetic material (DNA or RNA)Method of reproduction

Infection of cells to produce new viruses

Impacts in biotech

  1. Vaccines, therapies targeting the viral cycle
  2. Challenges
  3. Emergence of variants, resistance to antivirals

Fungi: multifunctional eukaryotic organisms in biotech

Fungi are like the eukaryote family, with all their complexities. They include unicellular organisms such as yeast, but also multicellular forms known as molds or larger fungi. Their role is just as essential in many sectors. They have a well-defined nucleus and a complex cellular structure, comparable to that of plants or animals.
Yeasts, in particular, are widely used in fermentation, for making bread, beer, and cheese. The Pierre Fabre company also relies on these microorganisms to produce innovative biomedicines. Molds, such as Penicillium, led to the discovery of penicillin, the first natural antibiotic, paving the way for a whole range of new therapeutics. In biotech, their ability to produce enzymes and active substances is invaluable. Controlled fermentation enables the synthesis of drugs, vaccines, and environmentally friendly raw materials. It is a sustainable alternative, particularly in the face of dwindling natural resources.
Characteristics Key Information
Type of Organism Eukaryotes, Unicellular or Multicellular
Applications in Biotech Production of Antibiotics, Enzymes, Vaccines

Cell Structure

Defined Nucleus, Organelles, Cell Wall Historical Significance Discovery of Penicillin, Industrial Fermentation Key Differences Between These Three Types of Microorganisms in Biotech To gain an overview, it is helpful to compare these three groups based on a few key points:

  • Criteria Bacteria Viruses
  • Fungi StructureProkaryote, unicellular
  • Part of the living, no cell of its own Eukaryote, unicellular or multicellularMetabolism

Autonomous, feeds on its environment

Infects a cell to reproduce Use fermentation or enzyme synthesis
Applications in biotechnology
Medicines, bioremediation, agriculture Vaccines, antiviral therapies
Food, drugs, industrial enzymes Risks
Pathogenic or beneficial Highly contagious diseases

Often harmless, except for certain toxic fungi

The impacts of these microorganisms on health and the environment in 2025

Advances in biotechnology mean that these microbes are not only harmful or beneficial, they are also becoming levers for treating, protecting, and preserving our planet. How? Beneficial bacteria, such as those in the intestinal microbiota, aid digestion and strengthen our defenses. Modified or synthetic viruses give rise to new vaccines, sometimes requiring a boost in just a few weeks. Fungi, through fermentation, contribute to the production of bioplastics or anti-infectious substances. Manufacturers such as Biomerieux, Novartis, Sanofi, and GSK are investing in research to exploit these modern microorganisms. With tools such as genome sequencing and advanced cell culture, they are paving the way for increasingly personalized, environmentally friendly, and innovative medicine in its biotechnological applications.
Discover the fascinating world of biotechnology, a discipline that combines biology and technology to develop innovative solutions in medicine, agriculture, and the environment. Explore how biotechnological advances are transforming our future. Frequently asked questions about the difference between bacteria, viruses, and fungi in biotech What is the main difference between bacteria and viruses? Bacteria are autonomous living organisms, capable of reproducing by division. Viruses, on the other hand, cannot live alone and depend on a host cell to multiply.
Are all fungi harmless in biotech? No, some can produce toxins or cause disease, but many are used for the production of drugs or sustainable bioproducts. How can these microorganisms be differentiated during technological research? Analytical techniques such as electrophoresis, spectroscopy, and cell culture allow them to be distinguished quickly and precisely.
What future does these microbes hold in the medicine of tomorrow? They will pave the way for more targeted treatments, the fight against resistance, and the development of vaccines at the cutting edge of modern biotechnology, with players such as Ipsen and Pierre Fabre leading the way.

Cet article vous a aidé ?

Recevez chaque semaine nos nouveaux guides BTS, fiches métier et ressources professionnelles.